Stock Price
11.89
Daily Change
0 0%
Monthly
4.99%
Yearly
-24.08%
Q3 Forecast
11.57

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 0.12 0.09
2026-07-30 FY2026Q2 0.24 0.22 0.22
2026-05-05 FY2026Q1 0.20 0.08 0.19
2026-03-04 FY2025Q4 0.23 0.23 0.25
2025-10-29 FY2025Q3 0.09 0.13 0.13



Peers Price Chg Day Year Date
Amplifon 11.89 0 0% -24.08% Aug/24
Brookdale Senior Living 12.12 0.32 2.71% 58.85% Aug/24
Cencora 323.77 5.73 1.80% 12.30% Aug/24
Diasorin 75.48 0.34 0.45% -12.62% Aug/24
Encompass Health 120.92 0.61 0.51% -1.04% Aug/24
Enovis 25.21 -0.85 -3.26% -18.65% Aug/24
GE HealthCare Technologies 74.19 -0.63 -0.84% -0.54% Aug/24
Pediatrix Medical Group 26.60 0.03 0.11% 23.89% Aug/24
Veradigm 4.90 -0.07 -1.41% 1.03% Aug/24
OPKO Health 444.50 6.80 1.55% -7.11% Aug/24

Indexes Price Day Year Date
IT40 52542 -125.87 -0.24% 21.55% Aug/24
EU600 654 0 0% 18.05% Aug/25

Amplifon traded at 11.89 this Monday August 24th. Looking back, over the last four weeks, Amplifon lost 4.99 percent. Over the last 12 months, its price fell by 24.08 percent. Looking ahead, we forecast Amplifon to be priced at 11.57 by the end of this quarter and at 10.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).